QuantuMDx is an member of the Stop TB Partnership Private Sector Constituency (PSC) and on World TB Day (24th March), we’re coming together to highlight the devastating health, social, and economic impact of tuberculosis (TB) and urge the global community to accelerate efforts to end this disease. It’s TIME!
It’s time to end TB.
TB is now the world’s deadliest infectious disease, claiming over 1.6 million lives and newly infecting an estimated 10 million people every year.
Nearly 1.7 billion people – around a quarter of the world’s population – have latent TB infection; without intervention, up to 10% of these individuals could develop active TB during their lifetime. Further, the emergence of drug-resistant TB (DR-TB) is now estimated to be responsible for one-third of all deaths due to antimicrobial resistance.
It’s time to accelerate impact and innovation in the fight against TB.
To end TB, we need to rapidly scale up existing, proven interventions, including new diagnostics, improved medicines, and technologies to support the care journey. At the same time, additional investment in innovation is urgently needed. Controlling and ultimately eliminating TB will require new approaches and technologies across the continuum of TB care.
It’s time to advance public-private partnership.
Winning the fight against TB can only be achieved through partnership and collaboration. The private sector is committed to playing a major role in this important effort, for example through research and development of improved data collection technologies, health information systems, new and innovative medicines and vaccines, as well as novel diagnostic approaches.
It’s time to replenish the Global Fund
The TB response needs more funding. On World TB Day, we call on governments, foundations, individuals and corporations to commit funding for the Global Fund to Fight AIDS, TB & Malaria.
It’s time to get involved. For more information on how you can contribute to the global fight against TB, visit http://stoptb.org/getinvolved/.
QuantuMDx is working with the TB community to deliver accurate, accessible diagnostic solutions that patients need. Here’s an infographic to tell you more, as well as details about our technology and collaboration with Molbio Diagnostics.